Patents Assigned to Immuno-Rx, Inc.
  • Publication number: 20110044941
    Abstract: A method for overcoming immune suppression includes the steps of inducing production of naïve T cells and restoring T cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naïve T cells and exposing the naïve T cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T cells to gain immunization of the T cells.
    Type: Application
    Filed: March 29, 2010
    Publication date: February 24, 2011
    Applicant: IMMUNO-RX, INC.
    Inventor: John W. Hadden
  • Patent number: 7731945
    Abstract: A method for overcoming immune suppression includes the steps of inducing production of naïve T cells and restoring T cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naïve T cells and exposing the naïve T cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T cells to gain immunization of the T cells.
    Type: Grant
    Filed: October 26, 2002
    Date of Patent: June 8, 2010
    Assignee: Immuno-Rx, Inc.
    Inventor: John W. Hadden